Pariet holder was changed from Janssen to Kolmar in 20 years

The insurance code is newly established from July due to the withdrawal of the Janssen plant in Hyangnam

The domestic license holder for 'Pariet', a PPI used for GERD, has been changed in 20 years.

 

As Janssen Korea operates the Hyangnam factory until next year, the manufacturer has finally changed.

 

Eisai Korea is in charge of sales.

 

According to related industries on the 3rd, the permit holders of Pariet licensed in 2000 were changed from Janssen Korea to Kolmar Korea, and an insurance code was newly established reflecting this from July.

 

Accordingly, items whose license holder is Janssen Korea can only be claimed by this December.

 

Since last year, Janssen Korea has been in the process of transferring manufacturing.

 

This is because the operation of the Hyangnam Plant until next year will no longer produce Pariet, which was commissioned and manufactured in Korea.

 

It is developed by Eisai, and Eisai Korea is in charge of sales.

 

Janssen Korea has established a relationship since Pariet launched in Korea in 2000.

 

In addition to permitting, manufacturing and production, the company also conducted joint sales with Eisai Korea.

 

It closed sales in 2015, and was transferred to Kolmar Korea at this time.

 

Pariet has recently released a low dose product, and is strengthening its marketing by conducting joint sales with Yuhan Corporation.

 

Pariet is also receiving reflex benefits according to anti-ulcer drug Ranitidine has been banned due to the detection of NDMA, a carcinogen, It is noteworthy whether Pariet, whose license has changed from Janssen Korea to Kolmar Korea in 20 years, will making its way up once again in Korea with a new partnership.